BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1078744)

  • 21. [Recent topics on immunologic disorders and physiopathology of systemic lupus erythematosus].
    Nagasawa K
    Fukuoka Igaku Zasshi; 1994 Apr; 85(4):111-4. PubMed ID: 8200607
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-DNA activity in Raji cell eluates of sera from patients with systemic lupus erythematosus.
    Tomii M
    Ryumachi; 1981; 21 Suppl():123-7. PubMed ID: 6979800
    [No Abstract]   [Full Text] [Related]  

  • 23. [Histocompatibility antigens. Immunologic and clinical importance].
    Berg PA
    Internist (Berl); 1974 Nov; 15(11):562-8. PubMed ID: 4617738
    [No Abstract]   [Full Text] [Related]  

  • 24. The role of anti-DNA idiotype antibodies in systemic lupus erythematosus.
    Mozes E; Mendlovic S
    Crit Rev Immunol; 1990; 10(4):329-45. PubMed ID: 2285460
    [No Abstract]   [Full Text] [Related]  

  • 25. [Complement binding anti-DNA antibodies: its clinical significance in systemic lupus erythematosus].
    Pigrau A; Martínez-Vázquez JM; Bacardí R; Ocanña I; Pahissa A
    Med Clin (Barc); 1984 Dec; 83(19):787-91. PubMed ID: 6335542
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial: Lymphocytotoxic antibodies.
    Lancet; 1976 Apr; 1(7963):785. PubMed ID: 56595
    [No Abstract]   [Full Text] [Related]  

  • 27. Antibodies to T cells in patients with systemic lupus erythematosus can induce antibody-dependent cell-mediated cytotoxicity against human T cells.
    Kumagai S; Steinberg AD; Green I
    J Clin Invest; 1981 Mar; 67(3):605-14. PubMed ID: 6970750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of a monoclonal anti-DNA autoantibody to identical protein(s) present at the surface of several human cell types involved in lupus pathogenesis.
    Jacob L; Lety MA; Louvard D; Bach JF
    J Clin Invest; 1985 Jan; 75(1):315-7. PubMed ID: 2578139
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Double-stranded DNA antibodies and lymphocyte subpopulations in disseminated lupus erythematosus].
    Rodeck U; Kreuzfelder E; Kuwert E; Rupprecht HJ; Brittinger G; Laubenthal F
    Med Welt; 1983 Jun; 34(24):692-3. PubMed ID: 6224999
    [No Abstract]   [Full Text] [Related]  

  • 30. Lymphopenia in Sjögren's syndrome with rheumatoid arthritis: relationship to lymphocytotoxic antibodies, cryoglobulinemia, and impaired mitogen responsiveness.
    Utsinger PD; Yount WJ
    J Rheumatol; 1976 Dec; 3(4):355-66. PubMed ID: 1088165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-lymphocyte antibodies in systemic lupus erythematosus.
    Winfield JB
    Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Biochemical aspects of the pathogenesis of systemic lupus erythematosus].
    Lebedev DA; Tikhomirov AV; Zamaraeva TV
    Ter Arkh; 1984; 56(5):126-30. PubMed ID: 6205461
    [No Abstract]   [Full Text] [Related]  

  • 33. The potential role of immunoregulatory disturbance in the pathogenesis of systemic lupus erythematosus.
    Bell DA
    J Rheumatol; 1981; 8(2):340-4. PubMed ID: 6971937
    [No Abstract]   [Full Text] [Related]  

  • 34. Pathogenesis of lupus.
    Oelke K; Richardson B
    Arthritis Rheum; 2002 Jun; 47(3):343-5. PubMed ID: 12115166
    [No Abstract]   [Full Text] [Related]  

  • 35. Modulation of T-cell-mediated regulation of antibody production by interaction with specific immune complexes.
    Clough JD; Calabrese LH; Budervic SA
    Clin Lab Med; 1988 Jun; 8(2):337-49. PubMed ID: 3284700
    [TBL] [Abstract][Full Text] [Related]  

  • 36. T cells in the pathogenesis of systemic lupus erythematosus.
    Hoffman RW
    Clin Immunol; 2004 Oct; 113(1):4-13. PubMed ID: 15380523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune mechanisms in the pathogenesis of systemic lupus erythematosus.
    Brunner CM; Davis JS
    Bull Rheum Dis; 1975-1976; 26(5-6):854-61. PubMed ID: 764905
    [No Abstract]   [Full Text] [Related]  

  • 38. Identification of DNA-binding lymphocytes in patients with systemic lupus erythematosus.
    Bankhurst AD; Williams RC
    J Clin Invest; 1975 Dec; 56(6):1378-85. PubMed ID: 1081549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Pathogenesis, diagnosis and therapy of transitional (presystemic) forms of lupus erythematosus].
    Shaposhnikov OK; Gorbunov VF
    Vestn Dermatol Venerol; 1981 Nov; (11):4-7. PubMed ID: 6976049
    [No Abstract]   [Full Text] [Related]  

  • 40. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
    Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
    Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.